Related Experiment Video
Updated: Jul 16, 2025

11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.0K
Association between Expanded Disability Status Scale score and dietary antioxidant capacity in patients with multiple
S Mungan1, I Guzel2, B C Demirdogen3
1Department of Neurology, University of Health Sciences Ankara City Hospital, Ankara, Turkey.
Summary
Dietary antioxidants may impact multiple sclerosis (MS) severity. Higher levels of vitamins A, D, and C were linked to better outcomes in MS patients, suggesting their potential role in managing this central nervous system disease.
Area of Science:
- Neurology
- Immunology
- Nutritional Science
Background:
- Multiple sclerosis (MS) is a leading cause of neuroinflammation and neurodegeneration, particularly affecting young adults.
- Antioxidant-rich diets are recognized for their potential to mitigate pro-inflammatory cytokine activity and improve MS prognosis.
Purpose of the Study:
- To investigate the relationship between dietary antioxidant capacity and Expanded Disability Status Scale (EDSS) scores in patients diagnosed with MS.
- To determine if specific antioxidant levels correlate with disease severity as measured by EDSS.
Main Methods:
- A cohort of 220 MS patients (137 women, 83 men) completed dietary questionnaires.
- Patients were stratified into two groups based on EDSS scores (≤5 and >5).
- Nutritional data were analyzed using BeBiS 4 software, assessing antioxidant levels and demographic factors.
Main Results:
- Significant differences in age and levels of vitamins A, D, E, C, and retinol were observed between the EDSS groups (P<0.05).
- Pearson's correlation analysis confirmed significant interrelationships among vitamins A, D, E, C, and retinol.
- Receiver operator characteristic curve analysis identified vitamins A, D, and C as key discriminating variables for patients with higher EDSS scores (>5).
Conclusions:
- Antioxidant levels, particularly vitamins A, D, and C, show potential as indicators of MS illness severity and treatment efficacy.
- These findings suggest that assessing antioxidant status could aid in managing MS patients.
- Further clinical trials focusing on potent antioxidants in MS patients are warranted.

